Analysis of aluminum-26 labeled aluminum chlorohydrate

被引:7
作者
Flarend, R
Keim, C
Bin, T
Elmore, D
Hem, S
Ladisch, M
机构
[1] Penn State Univ, Div Math & Nat Sci, Altoona, PA 16601 USA
[2] Purdue Univ, Dept Agr & Biol Engn, W Lafayette, IN 47907 USA
[3] Purdue Univ, Renewable Resources Engn Lab, W Lafayette, IN 47907 USA
[4] Purdue Univ, Dept Ind Pharm, W Lafayette, IN 47907 USA
[5] Purdue Univ, Dept Phys, PRIME Lab, W Lafayette, IN 47907 USA
关键词
aluminum chlorohydrate; antiperspirant; accelerator mass spectrometry; aluminum-26;
D O I
10.1016/S0162-0134(99)00127-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A small quantity of aluminum chlorohydrate (ACH), the active ingredient in antiperspirants, was labeled with the radioisotope Al-26. This labeled drug will be used in future studies to measure the absorption of aluminum from antiperspirant use. The purpose of this study was to demonstrate that the technique used to make the Al-26-labeled ACH resulted in a uniformly labeled complex, and therefore any measurement of Al-26 would be indicative of total aluminum. The labeled ACH was fractionated using gel filtration chromatography into 72 evenly spaced samples. The fractions were then measured for Al-26 and total aluminum content using accelerator mass spectrometry (AMS) and inductively coupled plasma atomic emission spectroscopy (ICP-AES). Results indicate that the ACH is uniformly labeled. (C) 1999 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:149 / 152
页数:4
相关论文
共 15 条
[1]   ALUMINUM TOXICITY IN PATIENTS WITH CHRONIC-RENAL-FAILURE [J].
ALFREY, AC .
THERAPEUTIC DRUG MONITORING, 1993, 15 (06) :593-597
[2]  
COVINGTON TR, 1990, HDB NONPRESCRIPTION
[3]   ACCELERATOR MASS-SPECTROMETRY FOR MEASUREMENT OF LONG-LIVED RADIOISOTOPES [J].
ELMORE, D ;
PHILLIPS, FM .
SCIENCE, 1987, 236 (4801) :543-550
[4]   Does antiperspirant use increase the risk of aluminium-related disease, including Alzheimer's disease? [J].
Exley, C .
MOLECULAR MEDICINE TODAY, 1998, 4 (03) :107-109
[5]  
FITZGERALD JJ, 1988, ANTIPERSPIRANTS DEOD, P35
[6]  
FLAREND RE, 1997, ALUMINIUM TOXICITY I, P6
[7]   THE ASSOCIATION BETWEEN ALUMINUM-CONTAINING PRODUCTS AND ALZHEIMERS-DISEASE [J].
GRAVES, AB ;
WHITE, E ;
KOEPSELL, TD ;
REIFLER, BV ;
VANBELLE, G ;
LARSON, EB .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1990, 43 (01) :35-44
[8]  
JASS HE, 1988, ANTIPERSPIRANTS DEOD, P35
[9]  
Laden K, 1988, ANTIPERSPIRANTS DEOD, P1
[10]   Gastrointestinal absorption of aluminum is increased in Down's syndrome [J].
Moore, PB ;
Edwardson, JA ;
Ferrier, IN ;
Taylor, GA ;
Lett, D ;
Tyrer, SP ;
Day, JP ;
King, SJ ;
Lilley, JS .
BIOLOGICAL PSYCHIATRY, 1997, 41 (04) :488-492